Literature DB >> 22345515

Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains.

Jennifer J Trowbridge1, Amit U Sinha, Nan Zhu, Mingjie Li, Scott A Armstrong, Stuart H Orkin.   

Abstract

Epigenetic mechanisms regulating leukemia stem cells (LSCs) are an attractive target for therapy of blood cancers. Here, we report that conditional knockout of the DNA methyltransferase Dnmt1 blocked development of leukemia, and haploinsufficiency of Dnmt1 was sufficient to delay progression of leukemogenesis and impair LSC self-renewal without altering normal hematopoiesis. Haploinsufficiency of Dnmt1 resulted in tumor suppressor gene derepression associated with reduced DNA methylation and bivalent chromatin marks. These results suggest that LSCs depend on not only active expression of leukemogenic programs, but also DNA methylation-mediated silencing of bivalent domains to enforce transcriptional repression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22345515      PMCID: PMC3289882          DOI: 10.1101/gad.184341.111

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  25 in total

1.  A bivalent chromatin structure marks key developmental genes in embryonic stem cells.

Authors:  Bradley E Bernstein; Tarjei S Mikkelsen; Xiaohui Xie; Michael Kamal; Dana J Huebert; James Cuff; Ben Fry; Alex Meissner; Marius Wernig; Kathrin Plath; Rudolf Jaenisch; Alexandre Wagschal; Robert Feil; Stuart L Schreiber; Eric S Lander
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

Review 2.  Epigenetics in cancer.

Authors:  Manel Esteller
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

5.  Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation.

Authors:  Stephanie Y Jo; Eric M Granowicz; Ivan Maillard; Dafydd Thomas; Jay L Hess
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

6.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

7.  Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells.

Authors:  Hanno Hock; Melanie J Hamblen; Heather M Rooke; Jeffrey W Schindler; Shireen Saleque; Yuko Fujiwara; Stuart H Orkin
Journal:  Nature       Date:  2004-09-29       Impact factor: 49.962

8.  Mutations in epigenetic modifiers in myeloid malignancies and the prospect of novel epigenetic-targeted therapy.

Authors:  Amir T Fathi; Omar Abdel-Wahab
Journal:  Adv Hematol       Date:  2011-06-26

9.  Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial.

Authors:  U Platzbecker; M Wermke; J Radke; U Oelschlaegel; F Seltmann; A Kiani; I-M Klut; H Knoth; C Röllig; J Schetelig; B Mohr; X Graehlert; G Ehninger; M Bornhäuser; C Thiede
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

10.  DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells.

Authors:  Jennifer J Trowbridge; Jonathan W Snow; Jonghwan Kim; Stuart H Orkin
Journal:  Cell Stem Cell       Date:  2009-10-02       Impact factor: 24.633

View more
  61 in total

Review 1.  Epigenetics in myelodysplastic syndromes.

Authors:  Michael Heuser; Haiyang Yun; Felicitas Thol
Journal:  Semin Cancer Biol       Date:  2017-08-02       Impact factor: 15.707

Review 2.  The epigenetic basis of hematopoietic stem cell aging.

Authors:  Ashley Kramer; Grant A Challen
Journal:  Semin Hematol       Date:  2016-10-24       Impact factor: 3.851

Review 3.  Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.

Authors:  Bin E Li; Patricia Ernst
Journal:  Exp Hematol       Date:  2014-09-28       Impact factor: 3.084

4.  Cell of origin determines clinically relevant subtypes of MLL-rearranged AML.

Authors:  A V Krivtsov; M E Figueroa; A U Sinha; M C Stubbs; Z Feng; P J M Valk; R Delwel; K Döhner; L Bullinger; A L Kung; A M Melnick; S A Armstrong
Journal:  Leukemia       Date:  2012-12-13       Impact factor: 11.528

Review 5.  The Role of Stem Cell DNA Methylation in Colorectal Carcinogenesis.

Authors:  Lele Song; Yuemin Li
Journal:  Stem Cell Rev Rep       Date:  2016-10       Impact factor: 5.739

Review 6.  Common stemness regulators of embryonic and cancer stem cells.

Authors:  Christiana Hadjimichael; Konstantina Chanoumidou; Natalia Papadopoulou; Panagiota Arampatzi; Joseph Papamatheakis; Androniki Kretsovali
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

Review 7.  Epigenetic regulation of hematopoietic stem cell aging.

Authors:  Isabel Beerman; Derrick J Rossi
Journal:  Exp Cell Res       Date:  2014-09-28       Impact factor: 3.905

8.  Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1.

Authors:  Dong Soon Choi; Elvin Blanco; Yoo-Shin Kim; Angel A Rodriguez; Hong Zhao; Tim Hui-Ming Huang; Chun-Liang Chen; Guangxu Jin; Melissa D Landis; Lacey A Burey; Wei Qian; Sergio M Granados; Bhuvanesh Dave; Helen H Wong; Mauro Ferrari; Stephen T C Wong; Jenny C Chang
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

9.  Loss of Dnmt3b accelerates MLL-AF9 leukemia progression.

Authors:  Y Zheng; H Zhang; Y Wang; X Li; P Lu; F Dong; Y Pang; S Ma; H Cheng; S Hao; F Tang; W Yuan; X Zhang; T Cheng
Journal:  Leukemia       Date:  2016-05-02       Impact factor: 11.528

10.  PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia.

Authors:  Christopher B Cole; Angela M Verdoni; Shamika Ketkar; Elizabeth R Leight; David A Russler-Germain; Tamara L Lamprecht; Ryan T Demeter; Vincent Magrini; Timothy J Ley
Journal:  J Clin Invest       Date:  2015-11-23       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.